Figure 3 Data

Includes all applicable data pertaining to Figure 3. Plate-bound stimulatory antibodies were used to activate PBMCs (n=3 canine donors) and frequency of activated CD5+ T cells was determined by cell surface expression of CD25. Different antibody doses were utilized to determine optimal dose for superior T cell activation. The stimulatory effects of four plate-bound αCD3+αCD28 antibody combinations (1:1 ratio) and two solitary plate-bound αCD3 antibodies were evaluated: CA17.6F9+5B8, CA17.2A12+5B8, CA17.6F9+1C6, CA17.2A12+1C6, CA17.6F9, and CA17.2A12. Data includes all applicable FCS and Prism files.